Arthur Donohue-Rolfe

Title: Arthur Donohue-Rolfe: Innovator in Shiga Toxin Research

Introduction

Arthur Donohue-Rolfe is a notable inventor based in Sudbury, MA (US), recognized for his contributions to the field of medical research, particularly in the area of Shiga toxins. He holds 2 patents that focus on innovative methods for detecting and treating diseases associated with these toxins.

Latest Patents

His latest patents include significant advancements in the understanding and treatment of Shiga toxin and Shiga-like toxins. One patent details a substantially pure antigenic peptide or protein related to Shiga toxin, which is crucial for developing vaccine formulations. This invention also outlines methods for treating disorders linked to Shiga toxins using effective amounts of the P1 glycoprotein. Additionally, it describes techniques for removing Shiga toxins from body fluids and methods for detecting related disorders. Another patent focuses on synthetic polypeptides corresponding to the Shiga B peptide chain, which can be used as effective vaccines to protect against Shiga toxin.

Career Highlights

Throughout his career, Arthur has worked with reputable organizations, including New England Medical Center Hospitals, Inc. and Yeda Research and Development & Co. Ltd. His work has significantly impacted the medical field, particularly in developing treatments for toxin-related diseases.

Collaborations

Arthur has collaborated with esteemed colleagues such as Gerald T. Keusch and David W. Acheson, contributing to the advancement of research in his field.

Conclusion

Arthur Donohue-Rolfe's innovative work in Shiga toxin research exemplifies the importance of scientific inquiry in developing effective medical treatments. His patents and collaborations highlight his commitment to improving health outcomes through innovation.